1. Thijs JL et al. Serum biomarker profiles suggest that
atopic dermatitis is a systemic disease. J Allergic Clin Immunol. (2018);
141(4):1523
2. Silverberg JI. Associations between atopic dermatitis and
other disorders. F1000Research (2018); 7(F1000 Faculty Rev):303
3. Al-Shobaili HA et al. Molecular Genetic of Atopic
dermatitis: An Update. International Journal of Health Sciences, Qassim
University (2016); 10(1)
4. Bieber T. Atopic dermatitis: an expanding therapeutic
pipeline for a complex disease. Nat Rev Drug Discov. (2021);1-20
5. Drucker AM et al. The Burden of Atopic Dermatitis: Summary
of a Report for the National Eczema Association. Journal of Investigative
Dermatology (2017); 137: 26-30
6. Moyle M et al. Understanding the immune landscape in atopic
dermatitis: The era of biologics and emerging therapeutic approaches.
Experimental Dermatology. (2019);28:756–768
7. Guttman-Yassky E et al. Once-daily upadacitinib versus
placebo in adolescents and adults with moderate-to-severe atopic dermatitis
(Measure Up 1 and Measure Up 2): results from two replicate double-blind,
randomised controlled phase 3 trials. Lancet (2021);397(10290):2151-2168
8. Kader HA et al. Current Insights into Immunology and Novel
Therapeutics of Atopic Dermatitis. Cells (2021); 10: 1392.